Levera (levetiracetam tablets) is an adjunctive therapy for treating partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients 1 month and older. Available in doses of 250 mg to 1000 mg, it may cause side effects such as dizziness and requires careful monitoring for suicidal thoughts. Contraindicated in hypersensitivity cases, overdoses can lead to severe symptoms, and it is classified as pregnancy category C due to potential risks to unborn children.